These observations support the hypothesis that the interaction between IGF2BP3 and HMGB1 mRNA, possibly mediated by m6A modifications, contributes to the regulation of HMGB1 expression in various tumors, including bladder cancer. This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.